Aptose Biosciences - 53 Year Dividend History | APTO
Historical dividend payout and yield for Aptose Biosciences (APTO) since 1971. The current TTM dividend payout for Aptose Biosciences (APTO) as of December 20, 2024 is $0.00. The current dividend yield for Aptose Biosciences as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.012B |
$0.000B |
|
Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
